Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Winquist

Showing results (121-130 of 234) with videos related to

Pageof 24
Sort By:
The Lancet. Oncology|May 28, 2013
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 studyYoo-Joung Ko, Christine M Canil, Som D Mukherjee, et al.
Cancer Research and Treatment|March 22, 2017
The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort StudyMalek B Hannouf, Eric Winquist, Salaheddin M Mahmud, et al.
Cureus|December 7, 2023
Clinical Presentation and Genomic Analysis of HPV-Related Squamous Cell Carcinoma of the Larynx in Two Young Female PatientsZahra Taboun, Peter Zeng, Jasna Deluce, et al.
Acta Oncologica (Stockholm, Sweden)|April 1, 2015
Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, CanadaChong S Kim, Malek B Hannouf, Sisira Sarma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combinationCarol A Townsley, Gregory R Pond, Amit M Oza, et al.
Annals of Internal Medicine|August 9, 2017
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysisShabbir M H Alibhai, Katherine Zukotynski, Cindy Walker-Dilks, et al.
Journal of Geriatric Oncology|November 25, 2020
Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic reviewAnupam Batra, Michele Marchioni, Ardeshir Z Hashmi, et al.
Urologic Oncology|May 24, 2005
A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancerEric Winquist, Malcolm J Moore, Kim N Chi, et al.
Cureus|March 7, 2024
Personalized Treatment of Recurrent, Metastatic Head and Neck Cancer Guided by Patient-Derived Xenograft ModelsMorgan D Black, John Yoo, Kevin Fung, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancerVictor A McPherson, George Rodrigues, Glenn Bauman, et al.
Pageof 24

Showing results (121-130 of 234) with videos related to

Sort By:
Pageof 24
The Lancet. Oncology|May 28, 2013
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 studyYoo-Joung Ko, Christine M Canil, Som D Mukherjee, et al.
Cancer Research and Treatment|March 22, 2017
The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort StudyMalek B Hannouf, Eric Winquist, Salaheddin M Mahmud, et al.
Cureus|December 7, 2023
Clinical Presentation and Genomic Analysis of HPV-Related Squamous Cell Carcinoma of the Larynx in Two Young Female PatientsZahra Taboun, Peter Zeng, Jasna Deluce, et al.
Acta Oncologica (Stockholm, Sweden)|April 1, 2015
Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, CanadaChong S Kim, Malek B Hannouf, Sisira Sarma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combinationCarol A Townsley, Gregory R Pond, Amit M Oza, et al.
Annals of Internal Medicine|August 9, 2017
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysisShabbir M H Alibhai, Katherine Zukotynski, Cindy Walker-Dilks, et al.
Journal of Geriatric Oncology|November 25, 2020
Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic reviewAnupam Batra, Michele Marchioni, Ardeshir Z Hashmi, et al.
Urologic Oncology|May 24, 2005
A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancerEric Winquist, Malcolm J Moore, Kim N Chi, et al.
Cureus|March 7, 2024
Personalized Treatment of Recurrent, Metastatic Head and Neck Cancer Guided by Patient-Derived Xenograft ModelsMorgan D Black, John Yoo, Kevin Fung, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancerVictor A McPherson, George Rodrigues, Glenn Bauman, et al.
Pageof 24